These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16941141)

  • 21. From the analysis of pharmacologic vitreolysis to the comprehension of ocriplasmin safety.
    Morescalchi F; Gambicorti E; Duse S; Costagliola C; Semeraro F
    Expert Opin Drug Saf; 2016 Sep; 15(9):1267-78. PubMed ID: 27388220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Objective of pharmacologic vitreolysis.
    Gandorfer A
    Dev Ophthalmol; 2009; 44():1-6. PubMed ID: 19494646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic Vitreolysis in Vascular Diseases of the Retina.
    Soliman MK; Agarwal A; Sarwar S; Hanout M; Sadiq MA; Do DV; Nguyen QD
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):60-8. PubMed ID: 26731211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic vitreolysis.
    Gandorfer A
    Dev Ophthalmol; 2007; 39():149-156. PubMed ID: 17245084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy.
    Gandorfer A; Putz E; Welge-Lüssen U; Grüterich M; Ulbig M; Kampik A
    Br J Ophthalmol; 2001 Jan; 85(1):6-10. PubMed ID: 11133703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of microplasmin on the clearance of vitreous haemorrhage from an experimental model in rabbits.
    Gad Elkareem AM; de Smet MD
    Acta Ophthalmol; 2014 Feb; 92(1):47-50. PubMed ID: 23025384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A placebo-controlled trial of microplasmin intravitreous injection to facilitate posterior vitreous detachment before vitrectomy.
    Benz MS; Packo KH; Gonzalez V; Pakola S; Bezner D; Haller JA; Schwartz SD
    Ophthalmology; 2010 Apr; 117(4):791-7. PubMed ID: 20138368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis.
    Stalmans P; Duker JS; Kaiser PK; Heier JS; Dugel PU; Gandorfer A; Sebag J; Haller JA
    Retina; 2013; 33(10):2003-11. PubMed ID: 23881226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronidase for pharmacologic vitreolysis.
    Narayanan R; Kuppermann BD
    Dev Ophthalmol; 2009; 44():20-25. PubMed ID: 19494648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic vitreolysis with plasmin and hyaluronidase in diabetic rats.
    Zhi-Liang W; Wo-Dong S; Min L; Xiao-Ping B; Jin J
    Retina; 2009 Feb; 29(2):269-74. PubMed ID: 19050667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progression of pharmacologic vitreolysis research].
    Zhou H; Ye J
    Zhonghua Yan Ke Za Zhi; 2014 Mar; 50(3):225-9. PubMed ID: 24841819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic vitreolysis.
    Sebag J
    Retina; 1998; 18(1):1-3. PubMed ID: 9502274
    [No Abstract]   [Full Text] [Related]  

  • 33. Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy.
    Chen W; Mo W; Sun K; Huang X; Zhang YL; Song HY
    Curr Eye Res; 2009 Dec; 34(12):1057-64. PubMed ID: 19958125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme-induced posterior vitreous detachment in the rat produces increased lens nuclear pO2 levels.
    Giblin FJ; Quiram PA; Leverenz VR; Baker RM; Dang L; Trese MT
    Exp Eye Res; 2009 Feb; 88(2):286-92. PubMed ID: 18835558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathology of Internal Limiting Membrane Specimens Following Intravitreal Injection of Ocriplasmin.
    Schumann RG; Wolf A; Mayer WJ; Compera D; Hagenau F; Ziada J; Kampik A; Haritoglou C
    Am J Ophthalmol; 2015 Oct; 160(4):767-78. PubMed ID: 26133247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme-induced vitreolysis can alleviate the progression of diabetic retinopathy through the HIF-1α pathway.
    Li C; Chen P; Zhang J; Zhang L; Huang X; Yao Y; Che X; Fan X; Ge S; Wang Z
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4964-70. PubMed ID: 23847321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of the anterior vitreous detachment induced by microplasmin, or pharmacologic vitreolysis to separate the posterior capsule from the anterior hyaloid.
    Van Looveren J; Tassignon MJ; De Smet M
    Bull Soc Belge Ophtalmol; 2011; (317):51-2. PubMed ID: 21560858
    [No Abstract]   [Full Text] [Related]  

  • 38. Microplasmin and tissue plasminogen activator: comparison of therapeutic effects in rat stroke model at multiparametric MR imaging.
    Chen F; Suzuki Y; Nagai N; Sun X; Wang H; Yu J; Marchal G; Ni Y
    Radiology; 2007 Aug; 244(2):429-38. PubMed ID: 17581889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymatic Vitrectomy and Pharmacologic Vitreodynamics.
    Shah AR; Trese MT
    Dev Ophthalmol; 2016; 55():357-64. PubMed ID: 26501959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of posterior vitreous detachment (PVD) by non-enzymatic reagents targeting vitreous collagen liquefaction as well as vitreoretinal adhesion.
    Santra M; Sharma M; Katoch D; Jain S; Saikia UN; Dogra MR; Luthra-Guptasarma M
    Sci Rep; 2020 May; 10(1):8250. PubMed ID: 32427865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.